<DOC>
	<DOCNO>NCT02854254</DOCNO>
	<brief_summary>In decompensation heart failure , may occur low cardiac output . For patient situation , use inotropic may necessary . Prolonged intravenous infusion inotropic agent lead phlebitis peripherally venous access . On hand , central venous access present complication inherent procedure . The peripherally inserted central catheter ( PICC ) may option situation . The present research project randomize clinical trial evaluate incidence phlebitis use PICC comparison peripheral venous access . The criteria inclusion : advanced congestive heart failure , use intravenous inotropic ; platelet &gt; 50.000 mm3 leave ventricular ejection fraction ( LVEF ) &lt; 0.45 . Patients randomize receive PICC keep peripheral venous access . The main outcome occurrence phlebitis . The sample size 40 patient group ( PICC control ) . The data analyze logistic regression . Will consider significant P 0.05 .</brief_summary>
	<brief_title>Peripherally Inserted Central Catheter Use Dobutamine Infusion Heart Failure Patients</brief_title>
	<detailed_description>Study design To evaluate incidence phlebitis use PICC compare peripheral venous access randomize clinical trial conduct period 12/07/2012 10/02/2014 , adult cardiology department university hospital Brazil . Patients randomize two group permute block four . The sequence randomization build random allocation block 4 random number table . ( 3 ) .The primary endpoint occurrence phlebitis . Population Patients admit congestive heart failure decompensated use intravenous inotropic agent screen eligibility participate study . Inclusion criterion : advanced congestive heart failure , use vasoactive drug , patient platelet ≥50.000 mm3 , leave ventricular ejection fraction &lt; 0.45 , upper limb venous system able catheter insertion central catheter peripherally insert . Exclusion criterion age &lt; 18 , cardiac pacemaker defibrillator , active systemic infection without treatment without control , platelet &lt; 50.000 mm3 , injury skin cubital region presence central catheter . Sample size calculation Based pilot study data , estimate occurrence phlebitis 20 % PICC group 80 % control group . Considering statistical power 80 % α-error 5 % , sample size estimate 39 patient group . For conservative estimation define 40 patient group ( 80 patient total ) .Considering value sample size 39 patient group conservative estimate set size 40 patient group 60 % control group 20 % PICC group . In total 172 patient evaluate , 86 patient meet inclusion criterion six agree participate . Ethics consideration Eligible patient invite participate receive write information study objectives procedure . After detailed explanation study patient agree participate sign informed consent . The study protocol approve local ethic committee , study accordance principle set Declaration Helsinki . ( 1989 ) Intervention endpoint Patients divide two group : PICC Group Control Group - peripheral venous access . In patient PICC group catheter insert researcher use puncture technique guide ultrasound ( 2 ) . In control group , patient maintain venous access peripheral vein flexible peripheral intravenous device evaluation similar PICC group . The researcher evaluate daily insertion site ask patient whether feel pain . The degree phlebitis consider accord phlebitis scale Infusion Nurses Society ( Table 1 ) . Daily photo catheter insertion site perform . The patient follow present outcome , phlebitis ; absence follow ten consecutive day . The dobutamine infusion prescribe responsible cardiologist well remain drug therapy . Statistical Analysis Categorical variable express number percentage compare group use chi-square test ( א 2 ) Fisher 's exact test . Continuous variable express mean , standard deviation variance compare group Student 's test . Kaplan-Meir free-event curve ( 4 ) build accord group . Logistic regression analysis examine predictive value PICC Group variables occurrence phlebitis , determine odds ratio 95 % confidence interval . Was consider statistically significant P &lt; 0.05 . The primary analysis respect principle intention treat , include randomized patient .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Advanced congestive heart failure In use intravenous inotropic Platelets &gt; 50.000 mm3 Left ventricular ejection fraction &lt; 0.45 Cardiac pacemaker implantable defibrillator Active uncontrolled systemic infection Skin disease , central venous catheter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>phlebitis</keyword>
	<keyword>catheter</keyword>
	<keyword>congestive heart failure</keyword>
	<keyword>dobutamine</keyword>
</DOC>